PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
12324759-1	2002	BACKGROUND: The purpose of this study was to retrospectively evaluate technetium 99m tetrofosmin (Tc-TF) uptake in parathyroid adenomas and compare the results with their expression of multidrug resistance-mediated 170-kDa P-glycoprotein (Pgp).	Technetium-99	70-83	ATP binding cassette subfamily B member 1	Homo sapiens	223-237
12324759-1	2002	BACKGROUND: The purpose of this study was to retrospectively evaluate technetium 99m tetrofosmin (Tc-TF) uptake in parathyroid adenomas and compare the results with their expression of multidrug resistance-mediated 170-kDa P-glycoprotein (Pgp).	Technetium-99	70-83	ATP binding cassette subfamily B member 1	Homo sapiens	239-242
12126530-1	2002	OBJECTIVE: To investigate the relationship between the uptake of technetium-99m methoxyisobutyl isonitrile ((99m)Tc-MIBI) and the expression of multidrug resistance genes mdr-1 and MRP in lung cancer so as to guide chemotherapy.	Technetium-99	65-78	ATP binding cassette subfamily B member 1	Homo sapiens	171-176
12146705-3	2002	Our purpose was to label an anti-CEA MoAb with technetium-99m (99Tc) and to validate a simplified animal model using a noncellular antigenic implant.	Technetium-99	47-60	carcinoembryonic antigen gene family	Mus musculus	33-36
12146705-3	2002	Our purpose was to label an anti-CEA MoAb with technetium-99m (99Tc) and to validate a simplified animal model using a noncellular antigenic implant.	Technetium-99	63-67	carcinoembryonic antigen gene family	Mus musculus	33-36
12126530-1	2002	OBJECTIVE: To investigate the relationship between the uptake of technetium-99m methoxyisobutyl isonitrile ((99m)Tc-MIBI) and the expression of multidrug resistance genes mdr-1 and MRP in lung cancer so as to guide chemotherapy.	Technetium-99	65-78	ATP binding cassette subfamily C member 1	Homo sapiens	181-184
12077713-10	2002	Tc 99m HMPAO-labeled leukocyte scintigraphy should be considered in the evaluation of patients with SpA.	Technetium-99	0-5	surfactant protein A2	Homo sapiens	100-103
11792176-3	2002	Such agents, when labeled with technetium-99m, might function as imaging agents for the dopamine transporter (DAT) system that would be useful for assessing the onset and severity of Parkinson"s disease.	Technetium-99	31-44	solute carrier family 6 member 3	Homo sapiens	88-108
11914895-3	2002	Technetium-99m labelled monoclonal anti-NCA-90 granulocyte antibody Fab" fragment (MN3 Fab") has been shown to be useful in bone and joint infection, but there are no data specifically referring to low-grade bone infection.	Technetium-99	0-13	FA complementation group B	Homo sapiens	68-71
11914895-3	2002	Technetium-99m labelled monoclonal anti-NCA-90 granulocyte antibody Fab" fragment (MN3 Fab") has been shown to be useful in bone and joint infection, but there are no data specifically referring to low-grade bone infection.	Technetium-99	0-13	FA complementation group B	Homo sapiens	87-90
11970764-7	2002	Technetium 99m ((99m)Tc)-sestamibi, an agent in clinical use for myocardial perfusion and tumor imaging, is recognized as a substrate for Pgp and MRP, and has been used to visualize Pgp expression.	Technetium-99	0-13	ATP binding cassette subfamily B member 1	Homo sapiens	138-141
11970764-7	2002	Technetium 99m ((99m)Tc)-sestamibi, an agent in clinical use for myocardial perfusion and tumor imaging, is recognized as a substrate for Pgp and MRP, and has been used to visualize Pgp expression.	Technetium-99	0-13	ATP binding cassette subfamily C member 1	Homo sapiens	146-149
11970764-7	2002	Technetium 99m ((99m)Tc)-sestamibi, an agent in clinical use for myocardial perfusion and tumor imaging, is recognized as a substrate for Pgp and MRP, and has been used to visualize Pgp expression.	Technetium-99	0-13	ATP binding cassette subfamily B member 1	Homo sapiens	182-185
11877745-0	2002	Alpha-melanocyte-stimulating hormone peptide analogs labeled with technetium-99m and indium-111 for malignant melanoma targeting.	Technetium-99	66-79	pro-opiomelanocortin-alpha	Mus musculus	0-36
11792176-3	2002	Such agents, when labeled with technetium-99m, might function as imaging agents for the dopamine transporter (DAT) system that would be useful for assessing the onset and severity of Parkinson"s disease.	Technetium-99	31-44	solute carrier family 6 member 3	Homo sapiens	110-113
11393758-0	2001	Technetium-99m labelling of glycosylated somatostatin-14.	Technetium-99	0-13	somatostatin	Homo sapiens	41-56
11578909-2	2001	Gluconate has been used as exchange ligand in the carrier added experiments and in the syntheses of 99Tc-CCK(4) and Re-CCK(4) complexes to be able to reproduce at macroscopic level the same chemical reactions occurring at non carrier added conditions.	Technetium-99	100-104	protein tyrosine kinase 7 (inactive)	Homo sapiens	105-110
24578056-1	2001	The purpose of this study was to determine the biodistribution and the associated radiation dose of technetium-99m 4,5-bis(thioacetamido)pentanoyl-annexin-V ((99m)Tc-Apomate), a tracer proposed for the study of apoptosis.	Technetium-99	100-113	annexin A5	Homo sapiens	147-156
10897007-3	2000	Scintigraphic breast images were obtained approximately 3-8 hours after the administration of technetium 99m ((99)Tc) labeled anti-CEA Fab" and correlated with histopathology.	Technetium-99	94-107	CEA cell adhesion molecule 3	Homo sapiens	131-134
11189941-0	2000	Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.	Technetium-99	54-67	ATP binding cassette subfamily C member 3	Homo sapiens	116-119
11545187-0	2001	Binding rate constant of Tc-99m DTPA galactosyl human serum albumin measured by quantitative dynamic SPECT--clinical evaluation as a total and regional liver function test.	Technetium-99	25-30	albumin	Homo sapiens	54-67
11315596-0	2001	Assessment of leg oedema by dynamic lymphoscintigraphy with intradermal injection of technetium-99m human serum albumin and load produced by standing.	Technetium-99	85-98	albumin	Homo sapiens	106-119
11315596-1	2001	This study was a preliminary evaluation of the utility of dynamic lymphoscintigraphy with technetium-99m human serum albumin (HSA) and a load produced by standing in the assessment of lymphatic dysfunction in patients with leg oedema.	Technetium-99	90-103	albumin	Homo sapiens	111-124
11245443-0	2001	P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings.	Technetium-99	83-96	ATP binding cassette subfamily B member 1	Homo sapiens	0-14
11245443-0	2001	P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings.	Technetium-99	83-96	chromosome 19 open reading frame 48	Homo sapiens	19-55
11321034-7	2001	Technetium-99m labeled annexin V localizes at sites of apoptosis in-vivo, due to its nanomolar affinity for membrane bound phosphatidylserine.	Technetium-99	0-13	annexin A5	Homo sapiens	23-32
11177537-5	2001	We first labeled an adenovirus expressing human CFTR with the gamma-emitting radioisotope, technetium 99m (99mTc), and determined the best labeling conditions to allow preservation of virus bioactivity.	Technetium-99	91-104	CF transmembrane conductance regulator	Homo sapiens	48-52
11891611-1	2001	Our aim was to use technetium-99m tetrofosmin (Tc-TF) uptake in non-small cell lung cancer (NSCLC) for predicting the chemotherapeutic response of NSCLC to paclitaxel and to compare the results with the expression of multidrug resistance (MDR) - P-glycoprotein (Pgp).	Technetium-99	19-32	ATP binding cassette subfamily B member 1	Homo sapiens	246-260
11891611-1	2001	Our aim was to use technetium-99m tetrofosmin (Tc-TF) uptake in non-small cell lung cancer (NSCLC) for predicting the chemotherapeutic response of NSCLC to paclitaxel and to compare the results with the expression of multidrug resistance (MDR) - P-glycoprotein (Pgp).	Technetium-99	19-32	ATP binding cassette subfamily B member 1	Homo sapiens	262-265
11150712-0	2000	A CD(4)/T(4) receptor peptide ligand labeled with technetium-99m: synthesis and biological activity.	Technetium-99	50-63	Cd4 molecule	Rattus norvegicus	2-21
10959989-0	2000	Solid-phase extraction of technetium--amine complexes onto C18 silica and its application to the isolation of 99Tc The extraction of Tc-tripentylamine complexes onto C18 silica solid-phase extraction columns is evaluated for the selective removal of 99Tc from other isotopes.	Technetium-99	110-114	Bardet-Biedl syndrome 9	Homo sapiens	166-169
10969653-5	2000	METHODS: Gene-modified ovarian cancer cells expressing the thymidine-kinase gene (PA1-STK) were radiolabeled with 99Tc and infused into the pleural space of 4 patients with malignant pleural mesothelioma, then scanned to determine distribution of the cells.	Technetium-99	114-118	PAXIP1 associated glutamate rich protein 1	Homo sapiens	82-85
10897007-3	2000	Scintigraphic breast images were obtained approximately 3-8 hours after the administration of technetium 99m ((99)Tc) labeled anti-CEA Fab" and correlated with histopathology.	Technetium-99	110-116	CEA cell adhesion molecule 3	Homo sapiens	131-134
10897007-3	2000	Scintigraphic breast images were obtained approximately 3-8 hours after the administration of technetium 99m ((99)Tc) labeled anti-CEA Fab" and correlated with histopathology.	Technetium-99	110-116	FA complementation group B	Homo sapiens	135-138
10779636-1	2000	We prospectively studied a total of 24 patients with breast cancer to evaluate the relationship between the degree of accumulation of technetium-99m sestamibi (Tc-99m MIBI) and p-glycoprotein (Pgp) expression in tumor tissues.	Technetium-99	134-147	ATP binding cassette subfamily B member 1	Homo sapiens	177-191
10779636-1	2000	We prospectively studied a total of 24 patients with breast cancer to evaluate the relationship between the degree of accumulation of technetium-99m sestamibi (Tc-99m MIBI) and p-glycoprotein (Pgp) expression in tumor tissues.	Technetium-99	134-147	ATP binding cassette subfamily B member 1	Homo sapiens	193-196
10741910-0	2000	Radioimmunodetection of residual, recurrent or metastatic germ cell tumors using technetium-99 anti-(alpha-fetoprotein) Fab" fragment.	Technetium-99	81-94	alpha fetoprotein	Homo sapiens	101-118
10928058-1	2000	We studied 30 patients with infiltrating ductal breast carcinomas to evaluate the relationship between the degree of accumulation of technetium-99m tetrofosmin (Tc-TETRO) and p-glycoprotein (Pgp) expression in breast tumor tissues.	Technetium-99	133-146	ATP binding cassette subfamily B member 1	Homo sapiens	175-189
10741910-0	2000	Radioimmunodetection of residual, recurrent or metastatic germ cell tumors using technetium-99 anti-(alpha-fetoprotein) Fab" fragment.	Technetium-99	81-94	FA complementation group B	Homo sapiens	120-123
10515333-8	1999	mdr1 and mrp were associated with 99Tc-sestamibi washout, but their role in the parathyroid remains unclear.	Technetium-99	34-38	ATP binding cassette subfamily B member 1	Homo sapiens	0-4
10823326-9	2000	In vivo studies with 99Tc(m)-labelled annexin confirm that radiolabelled annexin V can be used to image apoptotic cells/tissues in vivo.	Technetium-99	21-25	annexin A5	Homo sapiens	73-82
10515333-8	1999	mdr1 and mrp were associated with 99Tc-sestamibi washout, but their role in the parathyroid remains unclear.	Technetium-99	34-38	ATP binding cassette subfamily C member 1	Homo sapiens	9-12
10472350-1	1999	The aim of this study was to investigate the relationship between Technetium-99m (Tc-99m) tetrofosmin accumulation in tumors which may represent the expression of multidrug resistance (MDR)--mediated P-glycoprotein (Pgp) and multidrug resistance-associated protein (MRP) as well as response to chemotherapy in patients with untreated small cell lung cancers (SCLC).	Technetium-99	66-79	ATP binding cassette subfamily B member 1	Homo sapiens	200-214
10541822-0	1999	Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.	Technetium-99	0-13	annexin A5	Mus musculus	21-30
10541822-6	1999	We have coupled annexin V with the bifunctional hydrazinonicotinamide reagent (HYNIC) to prepare technetium-99m HYNIC-annexin V and demonstrated localization of radioactivity in tissues undergoing apoptosis in vivo.	Technetium-99	97-110	annexin A5	Mus musculus	16-25
10541822-6	1999	We have coupled annexin V with the bifunctional hydrazinonicotinamide reagent (HYNIC) to prepare technetium-99m HYNIC-annexin V and demonstrated localization of radioactivity in tissues undergoing apoptosis in vivo.	Technetium-99	97-110	annexin A5	Mus musculus	118-127
10436758-2	1999	Technetium-99m (Tc-99m) hexamethylpropylenamine (HMPAO) brain images were used to detect basal ganglion and cerebral cortex regional cerebral blood flow (rCBF) in patients with SLE with brain involvement.	Technetium-99	0-13	CCAAT/enhancer binding protein zeta	Rattus norvegicus	154-158
10541833-1	1999	Cerebral blood flow (CBF) has been quantified non-invasively using the brain perfusion index (BPI) determined from radionuclide angiographic data generated by technetium-99m hexamethylpropylene amine oxime( )((99m)Tc-HMPAO) or technetium-99m ethyl cysteinate dimer( )((99m)Tc-ECD).	Technetium-99	159-172	bactericidal permeability increasing protein	Homo sapiens	94-97
10429513-13	1999	Annexin V has been radiolabeled with Technetium-99m by direct coupling to free sulfhydryl groups, and through the hydrazinonicatinamide and N2S2 linking agents.	Technetium-99	37-50	annexin A5	Homo sapiens	0-9
10472350-1	1999	The aim of this study was to investigate the relationship between Technetium-99m (Tc-99m) tetrofosmin accumulation in tumors which may represent the expression of multidrug resistance (MDR)--mediated P-glycoprotein (Pgp) and multidrug resistance-associated protein (MRP) as well as response to chemotherapy in patients with untreated small cell lung cancers (SCLC).	Technetium-99	66-79	ATP binding cassette subfamily B member 1	Homo sapiens	216-219
10472350-1	1999	The aim of this study was to investigate the relationship between Technetium-99m (Tc-99m) tetrofosmin accumulation in tumors which may represent the expression of multidrug resistance (MDR)--mediated P-glycoprotein (Pgp) and multidrug resistance-associated protein (MRP) as well as response to chemotherapy in patients with untreated small cell lung cancers (SCLC).	Technetium-99	66-79	ATP binding cassette subfamily C member 3	Homo sapiens	225-264
10472350-1	1999	The aim of this study was to investigate the relationship between Technetium-99m (Tc-99m) tetrofosmin accumulation in tumors which may represent the expression of multidrug resistance (MDR)--mediated P-glycoprotein (Pgp) and multidrug resistance-associated protein (MRP) as well as response to chemotherapy in patients with untreated small cell lung cancers (SCLC).	Technetium-99	66-79	ATP binding cassette subfamily C member 3	Homo sapiens	266-269
10392376-1	1999	AIM: The purpose of this study was to assess the potential for radio-immunodetection (RAID) of murine anti-carcinoembryonic antigen (CEA) monoclonal antibody (MAb) F33-104 labeled with technetium-99m (99m-Tc) by a reduction-mediated labeling method.	Technetium-99	185-198	carcinoembryonic antigen gene family	Mus musculus	102-131
10392376-1	1999	AIM: The purpose of this study was to assess the potential for radio-immunodetection (RAID) of murine anti-carcinoembryonic antigen (CEA) monoclonal antibody (MAb) F33-104 labeled with technetium-99m (99m-Tc) by a reduction-mediated labeling method.	Technetium-99	185-198	carcinoembryonic antigen gene family	Mus musculus	133-136
9720670-0	1998	Alpha-1-antitrypsin labeling with technetium-99m for monitoring the deposition of alpha-1-antitrypsin in aerosol therapy.	Technetium-99	34-47	serpin family A member 1	Homo sapiens	0-19
9586878-1	1998	PURPOSE: Since we have previously shown that the efflux rate of technetium 99m (99mTc) sestamibi, a transport substrate of P-glycoprotein (Pgp), is directly correlated with Pgp levels in untreated breast carcinoma, we tested whether tumor clearance of 9mTc-sestamibi may be predictive of therapeutic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.	Technetium-99	64-77	ATP binding cassette subfamily B member 1	Homo sapiens	123-137
9600968-5	1998	In vivo localization of technetium 99m hydrazinonicotinamide-annexin V was tested in three models: fuminant hepatic apoptosis induced by anti-Fas antibody injection in BALB/c mice; acute rejection in ACI rats with transplanted heterotopic PVG cardiac allografts; and cyclophosphamide treatment of transplanted 38C13 murine B cell lymphomas.	Technetium-99	24-37	annexin A5	Mus musculus	61-70
9586878-1	1998	PURPOSE: Since we have previously shown that the efflux rate of technetium 99m (99mTc) sestamibi, a transport substrate of P-glycoprotein (Pgp), is directly correlated with Pgp levels in untreated breast carcinoma, we tested whether tumor clearance of 9mTc-sestamibi may be predictive of therapeutic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.	Technetium-99	64-77	ATP binding cassette subfamily B member 1	Homo sapiens	139-142
9586878-1	1998	PURPOSE: Since we have previously shown that the efflux rate of technetium 99m (99mTc) sestamibi, a transport substrate of P-glycoprotein (Pgp), is directly correlated with Pgp levels in untreated breast carcinoma, we tested whether tumor clearance of 9mTc-sestamibi may be predictive of therapeutic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.	Technetium-99	64-77	ATP binding cassette subfamily B member 1	Homo sapiens	173-176
9443738-14	1998	CONCLUSION: A recombinant MET containing scFv was successfully expressed, purified and labeled with 99Tc.	Technetium-99	100-104	immunglobulin heavy chain variable region	Homo sapiens	41-45
9021109-1	1997	A multicentre study on multicompartmental analysis of hepatic scintigraphy using technetium-99m labelled galactosyl serum albumin (GSA), which binds to the asialoglycoprotein receptor, was carried out at seven institutions in Japan.	Technetium-99	81-94	albumin	Homo sapiens	116-129
9380538-0	1997	Technetium-99m labelling of the IOR CEA 1 monoclonal antibody: evaluation of different methods.	Technetium-99	0-13	carcinoembryonic antigen-related cell adhesion molecule 1	Mus musculus	36-41
9259962-6	1997	Ten patients with elevated carcinoembryonic antigen (CEA) levels and no CT findings had a scintigraphy scan with an anti-CEA MoAb labeled with 99Tc.	Technetium-99	143-147	CEA cell adhesion molecule 3	Homo sapiens	121-124
9129773-7	1997	Tc 99m imaging of intraperitoneal catheters for insulin delivery can be used to assess catheter patency and impaired delivery into the peritoneal cavity.	Technetium-99	0-5	insulin	Homo sapiens	48-55
9227788-4	1997	Therefore, the current study evaluates the potential use of a new monoclonal antibody-based imaging agent, arcitumomab (CEA-Scan), which comprises an anti-carcinoembryonic antigen monoclonal antibody Fab" fragment labeled directly with technetium-99m, in the detection of primary, recurrent, or metastatic mammary cancer.	Technetium-99	236-249	CEA cell adhesion molecule 3	Homo sapiens	120-123
8662095-0	1996	Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.	Technetium-99	38-51	CEA cell adhesion molecule 3	Homo sapiens	67-70
8662095-0	1996	Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.	Technetium-99	38-51	BW26	Homo sapiens	92-100
8662095-2	1996	Technetium-99m labelled BW431/26, a monoclonal antibody against carcinoembryonic antigen (CEA), was used.	Technetium-99	0-13	BW26	Homo sapiens	24-32
8662095-2	1996	Technetium-99m labelled BW431/26, a monoclonal antibody against carcinoembryonic antigen (CEA), was used.	Technetium-99	0-13	CEA cell adhesion molecule 3	Homo sapiens	64-88
8662095-2	1996	Technetium-99m labelled BW431/26, a monoclonal antibody against carcinoembryonic antigen (CEA), was used.	Technetium-99	0-13	CEA cell adhesion molecule 3	Homo sapiens	90-93
8586081-2	1995	We compared different indices of transit time in a group of 30 patients having baseline and ACE inhibitor technetium-99m mercaptoacetyltriglycine (MAG3) renography prior to arteriography: peak time, mean transit time, and the ratio of background-subtracted counts at 20 min to those at 3 min.	Technetium-99	106-119	angiotensin I converting enzyme	Homo sapiens	92-95
8691466-0	1996	Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies.	Technetium-99	52-65	somatostatin receptor 3	Rattus norvegicus	0-21
8692479-1	1996	The aim of this study was to make a comparative evaluation of a direct and an indirect method for the labelling of anti-CEA with technetium-99m (99Tcm).	Technetium-99	129-142	CEA cell adhesion molecule 3	Homo sapiens	120-123
7493340-9	1995	The tumor uptake of 99Tc-labeled anti-carcinoembryonic antigen antibody was increased approximately 2-fold in rats pretreated with 70 micrograms of CA19-9-CVF, compared to animals that received an equimolar mixture of noncoupled mab and CVF.	Technetium-99	20-24	CEA cell adhesion molecule 20	Rattus norvegicus	38-62
8586084-2	1995	We evaluated the possibility of using an anti-serine protease (aprotinin) labelled with technetium-99m (TcA), usually employed as a cortical renal tracer, for the imaging of amyloid deposits.	Technetium-99	88-101	coagulation factor II, thrombin	Homo sapiens	46-61
8355083-0	1993	Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals.	Technetium-99	10-23	dipeptidase 1	Homo sapiens	25-28
7588942-0	1995	Upregulation of granulocyte CD11b (CR 3) after labelling with technetium-99m hexamethylpropylene amine oxime.	Technetium-99	62-75	integrin subunit alpha M	Homo sapiens	28-33
7588942-0	1995	Upregulation of granulocyte CD11b (CR 3) after labelling with technetium-99m hexamethylpropylene amine oxime.	Technetium-99	62-75	teratocarcinoma-derived growth factor 1 pseudogene 3	Homo sapiens	35-39
7828603-5	1994	Scans were performed following intraperitoneal administration of 500-1000 ml of 99Tc-labeled human serum albumin in normal saline.	Technetium-99	80-84	albumin	Homo sapiens	105-112
8491449-1	1993	Technetium 99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin is a newly developed analog ligand to asialoglycoprotein receptor, which is a hepatic cell surface receptor specific for galactose-terminated glycoproteins.	Technetium-99	0-13	albumin	Homo sapiens	67-80
8339729-0	1993	Technetium-99m labelled human serum albumin for ventriculography: a comparative evaluation of six labelling kits.	Technetium-99	0-13	albumin	Mus musculus	30-43
8491449-7	1993	We conclude that the parameter, asialoglycoprotein receptor concentration, obtained from the kinetic analysis of technetium 99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin time-activity data, is a sensitive measure of functioning hepatocyte mass in acute and chronic liver disease.	Technetium-99	113-126	albumin	Homo sapiens	180-193
8391686-3	1993	To address this issue, we conducted an in vitro, randomized, single-blind study using fenoterol MDI containing technetium-99m pertechnetate.	Technetium-99	111-124	MAFD2	Homo sapiens	96-99
8486395-0	1993	Technetium-99 m labelling of DD-3B6/22 antifibrin monoclonal antibody fragment Fab" for thrombus imaging.	Technetium-99	0-13	FA complementation group B	Homo sapiens	79-82
1730981-0	1992	An instant kit method for labeling antimyosin Fab" with technetium-99m: evaluation in an experimental myocardial infarct model.	Technetium-99	56-69	FA complementation group B	Homo sapiens	46-49
8404953-3	1993	The purpose of this study was to determine whether the hepatic uptake of dialysed technetium-99m labelled low-density lipoprotein (99mTc-LDL) reflects the hepatic LDL receptor activity and to what extent the non-LDL receptor-dependent 99mTc-LDL uptake by non-parenchymal cells relates to the diagnostic utility of quantitative 99mTc-LDL scintigraphy of the liver.	Technetium-99	82-95	low-density lipoprotein receptor	Oryctolagus cuniculus	163-175
8404956-2	1993	Technetium-99m radiolabelled 1A3, a monoclonal antibody against a columnar cell surface antigen, was used.	Technetium-99	0-13	CD53 molecule	Homo sapiens	75-95
1311185-2	1992	A retrospective review of a large series of patients with urinary tract disorders at the hospital for Sick Children, Great Ormond Street, identified 12 patients with vesico-ureteric reflux (VUR) with no evidence of scarring but with renal damage as assessed using technetium 99m dimercaptosuccinic acid (99mTc-DMSA) scan.	Technetium-99	264-277	VUR	Homo sapiens	190-193
2040339-0	1991	The APE nebuliser--a new delivery system for the alveolar targeting of particulate technetium 99m diethylene triamine penta-acetic acid.	Technetium-99	83-96	apurinic/apyrimidinic endodeoxyribonuclease 1	Homo sapiens	4-7
2087823-2	1990	First promising results were obtained with Technetium-99m labelled murine monoclonal antibodies against carcinoembryonic antigen (CEA).	Technetium-99	43-56	CEA cell adhesion molecule 3	Homo sapiens	104-128
2087823-2	1990	First promising results were obtained with Technetium-99m labelled murine monoclonal antibodies against carcinoembryonic antigen (CEA).	Technetium-99	43-56	CEA cell adhesion molecule 3	Homo sapiens	130-133
2164650-1	1990	Technetium-99m (99Tcm)(V) dimercaptosuccinic acid (DMSA) is a new tumour imaging agent which has been used to evaluate squamous carcinoma (SCC) of the head and neck.	Technetium-99	0-13	serpin family B member 3	Homo sapiens	139-142
2166552-0	1990	Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA.	Technetium-99	27-40	CEA cell adhesion molecule 3	Homo sapiens	67-70
2166552-0	1990	Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA.	Technetium-99	27-40	CEA cell adhesion molecule 3	Homo sapiens	146-149
2162508-1	1990	Technetium-99m (99Tcm) (v) dimercaptosuccinic acid (DMSA) is a new tumour imaging agent which has been used to image medullary carcinoma of the thyroid and squamous cell carcinoma (SCC) of the head and neck.	Technetium-99	0-13	serpin family B member 3	Homo sapiens	181-184
2162509-1	1990	Technetium-99m (99Tcm) (v) dimercaptosuccinic acid (DMSA) is a new tumour imaging agent which has been used to image squamous cell carcinoma (SCC) of the head and neck.	Technetium-99	0-13	serpin family B member 3	Homo sapiens	142-145
34596116-2	2021	We aimed to evaluate the DAT binding potential (DAT-BP) in a sample of healthy Brazilians through technetium-99 metastable TRODAT-1 single-photon emission computed tomography imaging.We selected 126 healthy individuals comprising 72 men and 54 women, aged 18 to 80 years.	Technetium-99	98-111	solute carrier family 6 member 3	Homo sapiens	25-28
34823954-1	2022	This study investigates the impacts of Ni doping on technetium-99 (Tc) sequestration in aqueous solutions through transformation of Fe(OH)2(s) to iron spinel (magnetite) under alkaline conditions.	Technetium-99	52-65	general transcription factor IIE subunit 1	Homo sapiens	132-139
34823954-1	2022	This study investigates the impacts of Ni doping on technetium-99 (Tc) sequestration in aqueous solutions through transformation of Fe(OH)2(s) to iron spinel (magnetite) under alkaline conditions.	Technetium-99	67-69	general transcription factor IIE subunit 1	Homo sapiens	132-139
34823954-8	2022	The finding of the metallic Tc encapsulation indicates that Tc sequestration through Ni-doped Fe(OH)2(s)-to-iron spinel transformation process likely provides an alternative treatment pathway for Tc removal and could be combined into further waste treatment approaches.	Technetium-99	28-30	general transcription factor IIE subunit 1	Homo sapiens	94-101
34823954-8	2022	The finding of the metallic Tc encapsulation indicates that Tc sequestration through Ni-doped Fe(OH)2(s)-to-iron spinel transformation process likely provides an alternative treatment pathway for Tc removal and could be combined into further waste treatment approaches.	Technetium-99	60-62	general transcription factor IIE subunit 1	Homo sapiens	94-101
34823954-8	2022	The finding of the metallic Tc encapsulation indicates that Tc sequestration through Ni-doped Fe(OH)2(s)-to-iron spinel transformation process likely provides an alternative treatment pathway for Tc removal and could be combined into further waste treatment approaches.	Technetium-99	196-198	general transcription factor IIE subunit 1	Homo sapiens	94-101
1964640-0	1990	Reduced technetium 99m labelled NCA-95/CEA-antibody uptake in liver due to gentle antibody reconstitution.	Technetium-99	8-21	CEA cell adhesion molecule 8	Homo sapiens	32-38
2586133-2	1989	Albumin aggregates (15 to 30 microns) labeled with technetium 99m were injected into the left ventricle during bypass (ventricle), the perfusion cannula during bypass (cannula), and the left ventricle with no bypass (control).	Technetium-99	51-64	albumin	Oryctolagus cuniculus	0-7
3581620-0	1987	Exercise-induced muscle uptake of technetium-99m MDP.	Technetium-99	34-47	dipeptidase 1	Homo sapiens	49-52
2495819-2	1989	The kinetic behavior of fibrin clot lysis as induced by tissue-type plasminogen activator (t-PA) was studied using proton magnetic resonance (PMR) and a release assay of fibrin labeled with technetium-99m isotope (99mTc).	Technetium-99	190-203	plasminogen activator, tissue type	Homo sapiens	91-95
2544690-1	1989	A recently developed imaging agent, technetium-99m (v) dimercaptosuccinic acid (99mTc (v) DMSA), has been used to assess head and neck squamous carcinoma (SCC).	Technetium-99	36-49	serpin family B member 3	Homo sapiens	155-158
2972815-1	1988	Technetium-99m isonitrile myocardial perfusion imaging was employed in a patient undergoing thrombolytic therapy with recombinant tissue plasminogen activator for acute anteroseptal myocardial infarction.	Technetium-99	0-13	chromosome 20 open reading frame 181	Homo sapiens	130-158
3168364-0	1988	Diffuse muscle uptake of technetium-99M MDP in a patient with lung cancer.	Technetium-99	25-38	dipeptidase 1	Homo sapiens	40-43
7131084-0	1982	Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen.	Technetium-99	0-13	fibrinogen beta chain	Homo sapiens	73-83
2822624-4	1987	These results indicate that the two 99Tc (NEP-DADT) complexes are syn and anti isomers (i.e. one isomer has the N-piperdinylethyl side chain located syn to the technetium oxo core while the other has this side chain located anti to the technetium oxo core).	Technetium-99	36-40	synemin	Homo sapiens	66-69
2822624-4	1987	These results indicate that the two 99Tc (NEP-DADT) complexes are syn and anti isomers (i.e. one isomer has the N-piperdinylethyl side chain located syn to the technetium oxo core while the other has this side chain located anti to the technetium oxo core).	Technetium-99	36-40	synemin	Homo sapiens	149-152
3698433-0	1986	Extraosseous uptake of technetium-99m MDP in secondary deposits of neuroblastoma.	Technetium-99	23-36	dipeptidase 1	Homo sapiens	38-41
4075669-0	1985	Dermal uptake of technetium-99m MDP in calcinosis cutis.	Technetium-99	17-30	dipeptidase 1	Homo sapiens	32-35
3902390-3	1985	It is concluded that radionuclide angiocardiography with technetium 99m macroaggregated albumin (99mTc MAA), followed immediately by a perfusion lung scan, may have a place in the evaluation of patients with refractory hypoxemia, since pulmonary embolism and/or right-to-left shunting are two of several causes of hypoxemia in the absence of congenital heart disease.	Technetium-99	57-70	MAA	Homo sapiens	103-106
6469268-2	1984	R11D10 Fab with a Ka of 5 X 10(8) M-1 was labeled with technetium-99m (99mTc) by the dithionite reduction method of technetium pertechnetate, via a bifunctional chelating agent, diethylene triamine pentaacetic acid (DTPA).	Technetium-99	55-68	FA complementation group B	Homo sapiens	7-10
5712340-0	1968	[Apropos of the use of human serum albumin labeled with technetium 99m in placental and pulmonary scintigraphy].	Technetium-99	56-69	albumin	Homo sapiens	35-42
5128133-0	1971	Pulmonary scanning using technetium 99m labeled macroaggregates of albumin prepared according to a new and simplified technique.	Technetium-99	25-38	albumin	Homo sapiens	67-74
6155355-0	1980	The valence state of technetium-99 in its complexes with bleomycin, 1-hydroxy-ethylidene-1,1-diphosphonate and human serum albumin.	Technetium-99	21-34	albumin	Homo sapiens	117-130
11496383-0	1979	[Evaluation of bone scintigraphy with pyrophosphate and fibrinogen labeled with technetium 99m in rheumatoid arthritis and other arthropathies].	Technetium-99	80-93	fibrinogen beta chain	Homo sapiens	56-66
499236-1	1979	We have investigated the suitability of five different commercially available kits which provide human serum albumin (HSA) labelled with technetium 99m (99mTc) for cardiac blood pool imaging.	Technetium-99	137-150	albumin	Homo sapiens	103-116
140151-0	1977	Labeling plasmin with technetium-99m for scintigraphic localization of thrombi.	Technetium-99	22-35	plasminogen	Homo sapiens	9-16
790607-0	1976	Dynamic scintiscanning with technetium-99m as a diagnostic aid in oliguria after renal transplant.	Technetium-99	28-41	activation induced cytidine deaminase	Homo sapiens	59-62
33642158-0	2021	Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CT.	Technetium-99	52-65	albumin	Homo sapiens	82-89
31432660-6	2019	99Tc(VII) is more easily reduced than Re(VII) in the presence of NO3- with very slow redissolution of reduced 99Tc.	Technetium-99	0-4	NBL1, DAN family BMP antagonist	Homo sapiens	65-68
33259032-3	2020	Technetium-99 m [99mTc]-labelled anti-PD-L1 single-domain antibody (NM-01) SPECT/CT quantification correlates with PD-L1 expression in NSCLC, presenting an opportunity for non-invasive assessment.	Technetium-99	0-13	CD274 molecule	Homo sapiens	38-43
33259032-3	2020	Technetium-99 m [99mTc]-labelled anti-PD-L1 single-domain antibody (NM-01) SPECT/CT quantification correlates with PD-L1 expression in NSCLC, presenting an opportunity for non-invasive assessment.	Technetium-99	0-13	CD274 molecule	Homo sapiens	115-120
33906800-7	2021	In the first part of the review, we report on the diagnostic efficacy of various PSMA imaging radiotracers labeled with gallium-68, fluorine-18, and technetium-99m.	Technetium-99	149-162	folate hydrolase 1	Homo sapiens	81-85
31234464-6	2019	SPECT/CT imaging in mice following intravenous injection of Technetium-99m (99mTc)-labeled sdAb K2 revealed high signal-to-noise ratios, strong ability to specifically detect PD-L1 in melanoma and breast tumors, and relatively low kidney retention, which is a unique property for radiolabeled sdAbs.	Technetium-99	60-73	CD274 antigen	Mus musculus	175-180
30843155-0	2019	Impaired brain dopamine transporter in chemobrain patients submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1.	Technetium-99	102-115	solute carrier family 6 member 3	Homo sapiens	15-35
30325581-1	2019	It has been suggested that technetium-99m (99mTc)-anti-tumour necrosis factor alpha (TNF-alpha) scintigraphy (SCI) may be a useful diagnostic tool in Graves" ophthalmopathy (GO).	Technetium-99	27-40	tumor necrosis factor	Homo sapiens	85-94
30250607-1	2018	The present study aimed to label ZHER2:V2 with technetium-99m (99mTc) using a simple method and to evaluate its clinical potential as a diagnostic probe for human epidermal growth factor receptor type 2 (HER2)-positive tumors.	Technetium-99	47-60	erb-b2 receptor tyrosine kinase 2	Homo sapiens	34-38
30421571-0	2019	Effect of technetium-99 conjugated with methylene diphosphonate (99 Tc-MDP) on OPG/RANKL/RANK system in vitro.	Technetium-99	10-23	tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)	Mus musculus	79-82
30421571-0	2019	Effect of technetium-99 conjugated with methylene diphosphonate (99 Tc-MDP) on OPG/RANKL/RANK system in vitro.	Technetium-99	10-23	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	83-88
30650563-0	2019	Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m.	Technetium-99	116-129	cholecystokinin B receptor	Homo sapiens	0-26
30843003-14	2019	Such a single occult metastasis causing very high levels of PSA has been presented using technetium-99m (99m Tc) labeled PSMA imaging.	Technetium-99	89-102	kallikrein related peptidase 3	Homo sapiens	60-63
30843003-14	2019	Such a single occult metastasis causing very high levels of PSA has been presented using technetium-99m (99m Tc) labeled PSMA imaging.	Technetium-99	89-102	folate hydrolase 1	Homo sapiens	121-125
30324468-1	2019	BACKGROUND: This study evaluated the effect of technetium-99m (99mTc)-labeled prostate-specific membrane antigen (PSMA)-based image-guided surgery on the oncologic outcomes for patients with primary or recurrent prostate cancer (PCa).	Technetium-99	47-60	folate hydrolase 1	Homo sapiens	78-112
30324468-1	2019	BACKGROUND: This study evaluated the effect of technetium-99m (99mTc)-labeled prostate-specific membrane antigen (PSMA)-based image-guided surgery on the oncologic outcomes for patients with primary or recurrent prostate cancer (PCa).	Technetium-99	47-60	folate hydrolase 1	Homo sapiens	114-118
30406140-1	2018	Technetium-99 conjugated with methylene diphosphonate (99Tc-MDP) is an effective anti-inflammatory drug in treating rheumatoid arthritis (RA) for over 15 years in China.	Technetium-99	0-13	dipeptidase 1	Homo sapiens	60-63
30301182-4	2018	The aim of this work was to study physico-chemical and biological properties of different SP analogues labeled with technetium-99m and lutetium-177 radionuclides.	Technetium-99	116-129	tachykinin precursor 1	Homo sapiens	90-92
30165015-3	2018	Here, we show that natural H-ferritin nanocages radiolabeled with technetium-99m (99mTc-HFn) can identify and accurately localize macrophage-rich, atherosclerotic plaques in living mice using combined SPECT and CT. Focal 99mTc-HFn uptake was observed in the atherosclerotic plaques with multiple high-risk features of macrophage infiltration, active calcification, positive remodeling, and necrosis on histology and in early active ongoing lesions with intense macrophage infiltration.	Technetium-99	66-79	ferritin heavy polypeptide 1	Mus musculus	27-37
29864241-4	2018	We radiolabeled the CFTR inhibitor, CFTRinh -172a, with technetium-99m via a pyrazolyl-diamine chelating unit, yielding a novel 99m Tc(CO)3 complex.	Technetium-99	56-69	CF transmembrane conductance regulator	Homo sapiens	20-24
27937056-2	2017	METHOD: We compared the results of scintigraphy and MRI in two patients with psoriatic arthritis who underwent technetium-99m (99mTc)-anti-TNF-alpha scintigraphy, and MRI 5 days later.	Technetium-99	111-124	tumor necrosis factor	Homo sapiens	139-148
28925879-0	2018	Human Fibronectin Extra-Domain B (EDB)-Specific Aptide (APTEDB) Radiolabelling with Technetium-99m as a Potent Targeted Tumour-Imaging Agent.	Technetium-99	84-97	fibronectin 1	Homo sapiens	18-32
28925879-0	2018	Human Fibronectin Extra-Domain B (EDB)-Specific Aptide (APTEDB) Radiolabelling with Technetium-99m as a Potent Targeted Tumour-Imaging Agent.	Technetium-99	84-97	fibronectin 1	Homo sapiens	34-37
27981470-6	2017	PROCEDURES: Mouse IgG without specificity to biomolecules was labeled with technetium-99m via 6-hydrazinonicotinate to yield [99mTc]IgG.	Technetium-99	75-88	immunoglobulin heavy variable V1-62	Mus musculus	18-21
27981470-6	2017	PROCEDURES: Mouse IgG without specificity to biomolecules was labeled with technetium-99m via 6-hydrazinonicotinate to yield [99mTc]IgG.	Technetium-99	75-88	immunoglobulin heavy variable V1-62	Mus musculus	132-135
27998671-0	2017	Synthesis, physicochemical and biological studies of technetium-99m labeled tacrine derivative as a diagnostic tool for evaluation of cholinesterase level.	Technetium-99	53-66	butyrylcholinesterase	Homo sapiens	134-148
28586008-3	2017	In the present study, the targeting effects of an anti-CEA nanobody obtained from phage display were investigated using technetium-99 m (99mTc) and fluorescence labeling.	Technetium-99	120-133	CEA cell adhesion molecule 3	Homo sapiens	55-58
26954010-1	2016	Purpose To examine the relation between the lung elimination rate of inhaled technetium 99m ((99m)Tc)-sestamibi and immunohistochemical expression of bronchopulmonary multidrug resistance protein 1 (MRP1) and permeability glycoprotein (P-gp) and assess the repeatability of the inhaled (99m)Tc-sestamibi clearance technique.	Technetium-99	77-90	ATP binding cassette subfamily B member 1	Homo sapiens	167-197
27635026-7	2017	Putting hNIS under a late synthetic promoter allowed a higher functional expression of the protein and much stronger 123I or 99Tc uptake.	Technetium-99	125-129	solute carrier family 5 member 5	Homo sapiens	8-12
27574992-2	2016	The objective of this study was to characterize c[CTPSPFSHC]OH (TCP-1), a small peptide derived from phage display selection, for targeting human CRC xenografts using technetium-99m ((99m)Tc)-labeled TCP-1 and fluorescent cyanine-7 (Cy7)-labeled form of the peptide (Cy7-TCP-1).	Technetium-99	167-180	t-complex 1	Homo sapiens	64-69
26923781-4	2016	OBJECTIVE: The aim of this study was to evaluate the biodistribution of Technetium-99m (99mTc)-Aprotinin solution (99mTc-Aprotinin-S) and 99mTc-Aprotinin loaded microemulsion, which was prepared for the aim of treatment for acute pancreatitis.	Technetium-99	72-85	pancreatic trypsin inhibitor	Bos taurus	95-104
26954010-1	2016	Purpose To examine the relation between the lung elimination rate of inhaled technetium 99m ((99m)Tc)-sestamibi and immunohistochemical expression of bronchopulmonary multidrug resistance protein 1 (MRP1) and permeability glycoprotein (P-gp) and assess the repeatability of the inhaled (99m)Tc-sestamibi clearance technique.	Technetium-99	77-90	ATP binding cassette subfamily B member 1	Homo sapiens	199-203
27459001-3	2016	With the goal of preparing technetium-99(m) complexes that bind to Abeta plaques with the potential to be diagnostic imaging agents for Alzheimer"s disease, new tetradentate ligands capable of forming neutral and lipophilic complexes with oxotechentium(V) and oxorhenium(V) were prepared.	Technetium-99	27-40	amyloid beta precursor protein	Homo sapiens	67-72
26657217-1	2016	The labeling of leukocytes with technetium-99m (Tc)-HMPAO is a frequent procedure in our laboratory, which was first validated before initiation of clinical studies with the commercial kit of Tc-D,L-hexamethylpropylene amine oxime (Tc-D,L-HMPAO), available from 1988.	Technetium-99	32-45	CHM Rab escort protein	Homo sapiens	192-196
27246977-1	2016	PURPOSE: We aimed to develop and translate a CD20-antigen-targeted radiopharmaceutical, Technetium-99 m-labeled (99mTc) rituximab, for sentinel lymph node (SLN) detection.	Technetium-99	88-101	keratin 20	Homo sapiens	45-49
27073620-1	2016	Technetium 99 conjugated with methylene diphosphonate, which is an anti-inflammatory drug, can inhibit macrophage infiltration and downregulate a number of proinflammatory cytokines, such as tumor necrosis factor-alpha and interleukin-1beta.	Technetium-99	0-13	tumor necrosis factor	Homo sapiens	191-218
27073620-1	2016	Technetium 99 conjugated with methylene diphosphonate, which is an anti-inflammatory drug, can inhibit macrophage infiltration and downregulate a number of proinflammatory cytokines, such as tumor necrosis factor-alpha and interleukin-1beta.	Technetium-99	0-13	interleukin 1 beta	Homo sapiens	223-240
26657217-1	2016	The labeling of leukocytes with technetium-99m (Tc)-HMPAO is a frequent procedure in our laboratory, which was first validated before initiation of clinical studies with the commercial kit of Tc-D,L-hexamethylpropylene amine oxime (Tc-D,L-HMPAO), available from 1988.	Technetium-99	32-45	CHM Rab escort protein	Homo sapiens	232-236
25537093-1	2015	PURPOSE: Technetium-99 m (Tc-99 m)-labelled microparticles, functionalized with fucoidan to present a high affinity for P-Selectin, or [(99m)Tc] MP-fucoidan, were developed as a novel SPECT radiotracer for abdominal aortic aneurysm (AAA).	Technetium-99	9-22	selectin P	Homo sapiens	120-130
26792952-3	2016	The distribution ratios of 99Tc with lower than +VII oxidation state ionic species between 4 M H2SO4 and 30 % TBP/kerosene were found and are significantly lower than for TcO4- in the same solution.	Technetium-99	27-31	TATA-box binding protein	Homo sapiens	110-113
26622829-3	2015	The present study aimed to develop a technetium-99m (99mTc)-labeled uPAR-binding peptide for non-invasive single-photon emission computed tomography (SPECT) assessment of uPAR expression in pancreatic cancer xenograft models.	Technetium-99	37-50	plasminogen activator, urokinase receptor	Homo sapiens	68-72
26622829-3	2015	The present study aimed to develop a technetium-99m (99mTc)-labeled uPAR-binding peptide for non-invasive single-photon emission computed tomography (SPECT) assessment of uPAR expression in pancreatic cancer xenograft models.	Technetium-99	37-50	plasminogen activator, urokinase receptor	Homo sapiens	171-175
25440878-0	2014	Synthesis, physicochemical and biological evaluation of technetium-99m labeled lapatinib as a novel potential tumor imaging agent of Her-2 positive breast cancer.	Technetium-99	56-69	erb-b2 receptor tyrosine kinase 2	Homo sapiens	133-138
23763985-1	2013	Technetium 99m (99mTc)-annexin A5, a marker of ongoing apoptosis, is supposed to be useful in the detection of metabolically active atheroma.	Technetium-99	0-13	annexin A5	Mus musculus	23-33
25397621-2	2014	Methylene diphosphonate-technetium-99m ((99m)Tc-MDP) 3-phase bone scan is considered the most sensitive imaging method for the detection of jaw osteonecrosis at an early stage.	Technetium-99	24-37	dipeptidase 1	Homo sapiens	48-51
23759825-0	2014	An estimate of the inventory of technetium-99 in the sub-tidal sediments of the Irish Sea.	Technetium-99	32-45	S13 erythroblastosis (avian) oncogene homolog	Homo sapiens	86-89
23759825-1	2014	Published results from earlier studies have provided indications that measurable quantities of technetium-99 ((99)Tc) have accumulated in the sub-tidal sediments of the Irish Sea.	Technetium-99	95-108	S13 erythroblastosis (avian) oncogene homolog	Homo sapiens	175-178
23013134-0	2012	Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-kappaB ligand-induced osteoclastogenesis.	Technetium-99	0-13	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	63-113
23465564-0	2013	Preliminary studies of acetylcholinesterase activity in the rat brain using N-phenylferrocenecarboxamide labelled by the technetium-99m.	Technetium-99	121-134	acetylcholinesterase	Rattus norvegicus	23-43
23013134-2	2012	In the present study, we investigated the effects of technetium-99 conjugated with methylene diphosphonate ((99)Tc-MDP), an agent used in radionuclide therapy, on receptor activator of nuclear factor-kappaB ligand (RANKL)-induced osteoclastogenesis and explored the underlying mechanisms.	Technetium-99	53-66	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	163-213
23013134-2	2012	In the present study, we investigated the effects of technetium-99 conjugated with methylene diphosphonate ((99)Tc-MDP), an agent used in radionuclide therapy, on receptor activator of nuclear factor-kappaB ligand (RANKL)-induced osteoclastogenesis and explored the underlying mechanisms.	Technetium-99	53-66	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	215-220
22469241-1	2012	As apoptosis occurs over an interval of time after administration of apoptosis-inducing therapy in tumors, the changes in technetium 99m ((99m)Tc)-tricarbonyl (CO)3 His-annexin A5 (His-ann A5) accumulation over time were examined.	Technetium-99	122-135	annexin A5	Mus musculus	169-179
22409267-2	2012	This study evaluated the pharmacokinetic profile of a CCK-2 receptor-specific peptide, Demogastrin 1, labeled with technetium-99m ((99m)Tc-Demogastrin 1), in rats.	Technetium-99	115-128	cholecystokinin B receptor	Rattus norvegicus	54-68
21873267-2	2011	METHODS: Eight patients with active RA, 28-joint DAS (DAS-28) >= 3.2 and a healthy volunteer underwent whole body and hand/wrist scintigraphy after the administration of anti-human TNF-alpha labelled with technetium-99m ((99m)Tc).	Technetium-99	208-221	tumor necrosis factor	Homo sapiens	184-193
19430321-1	2009	AIM: To evaluate the stability of the mixture of technetium-99m (99mTc) human serum albumin (HSA) with the local anesthetic lidocaine hydrochloride.	Technetium-99	49-62	albumin	Homo sapiens	78-91
21666238-0	2011	Technetium-99 conjugated with methylene diphosphonate (99Tc-MDP) inhibits experimental choroidal neovascularization in vivo and VEGF-induced cell migration and tube formation in vitro.	Technetium-99	0-13	vascular endothelial growth factor A	Mus musculus	128-132
20538463-2	2010	In this study, we synthesized technetium-99m labeled 1,2,3-triazole-4-yl c-Met binding peptide (cMBP) derivatives, prepared by solid phase peptide synthesis and the "click-to-chelate" protocol for the introduction of tricarbonyl technetium-99m, as a potential c-Met receptor kinase positive tumor imaging agent, and evaluated their in vitro c-Met binding affinity, cellular uptake, and stability.	Technetium-99	30-43	MET proto-oncogene, receptor tyrosine kinase	Homo sapiens	73-78
20538463-2	2010	In this study, we synthesized technetium-99m labeled 1,2,3-triazole-4-yl c-Met binding peptide (cMBP) derivatives, prepared by solid phase peptide synthesis and the "click-to-chelate" protocol for the introduction of tricarbonyl technetium-99m, as a potential c-Met receptor kinase positive tumor imaging agent, and evaluated their in vitro c-Met binding affinity, cellular uptake, and stability.	Technetium-99	30-43	MET proto-oncogene, receptor tyrosine kinase	Homo sapiens	260-265
20538463-2	2010	In this study, we synthesized technetium-99m labeled 1,2,3-triazole-4-yl c-Met binding peptide (cMBP) derivatives, prepared by solid phase peptide synthesis and the "click-to-chelate" protocol for the introduction of tricarbonyl technetium-99m, as a potential c-Met receptor kinase positive tumor imaging agent, and evaluated their in vitro c-Met binding affinity, cellular uptake, and stability.	Technetium-99	30-43	MET proto-oncogene, receptor tyrosine kinase	Homo sapiens	260-265
20538463-2	2010	In this study, we synthesized technetium-99m labeled 1,2,3-triazole-4-yl c-Met binding peptide (cMBP) derivatives, prepared by solid phase peptide synthesis and the "click-to-chelate" protocol for the introduction of tricarbonyl technetium-99m, as a potential c-Met receptor kinase positive tumor imaging agent, and evaluated their in vitro c-Met binding affinity, cellular uptake, and stability.	Technetium-99	229-242	MET proto-oncogene, receptor tyrosine kinase	Homo sapiens	73-78
20346867-0	2010	Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.	Technetium-99	30-43	gastrin releasing peptide	Homo sapiens	63-71
20346867-0	2010	Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.	Technetium-99	30-43	gastrin releasing peptide	Homo sapiens	104-112
20152713-0	2010	A 1-methyl-4-piperidinyl cytectrene carboxylate labeled by the technetium 99m, a radiotracer for rat brain acetylcholinesterase activity.	Technetium-99	63-76	acetylcholinesterase	Rattus norvegicus	107-127
20152713-3	2010	Our aim was to study AChE activity using piperidinyl ester labelled with technetium-99m.	Technetium-99	73-86	acetylcholinesterase	Rattus norvegicus	21-25
20936711-0	2011	Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.	Technetium-99	60-73	epidermal growth factor receptor	Mus musculus	83-115
20411168-3	2010	Scintigraphy for the detection of SLN was performed 2-4h before surgery by injecting technetium-99m labeled nanocolloid intradermally in the peritumoral region.	Technetium-99	85-98	sarcolipin	Homo sapiens	34-37
17540565-0	2008	WITHDRAWN: Predicting multidrug resistance-related protein and P-glycoprotein expression with technetium-99m tetrofosmin mammoscintigraphy.	Technetium-99	94-107	chromosome 19 open reading frame 48	Homo sapiens	22-58
18992656-1	2008	OBJECTIVES: We examined the sodium-iodide symporter (NIS), which promotes in vivo cellular uptake of technetium 99m ((99m)Tc) or iodine 124 ((124)I), as a reporter gene for cell tracking by single-photon emission computed tomography (SPECT) or positron emission tomography (PET) imaging.	Technetium-99	101-114	solute carrier family 5 member 5	Rattus norvegicus	28-51
17540565-0	2008	WITHDRAWN: Predicting multidrug resistance-related protein and P-glycoprotein expression with technetium-99m tetrofosmin mammoscintigraphy.	Technetium-99	94-107	ATP binding cassette subfamily B member 1	Homo sapiens	63-77
17921030-1	2007	In the past 10 years, significant progress has been made in using a technetium-99m dopamine transporter imaging agent, [99mTc]TRODAT, for routine clinical studies.	Technetium-99	68-81	solute carrier family 6 member 3	Homo sapiens	83-103
18220774-9	2008	In some preliminary publications, several authors reported on the in vivo use of caspase-inhibitors and annexin V, labeled with indium-111, technetium-99m, iodine-123, iodine-124 or fluoride-18.	Technetium-99	140-153	annexin A5	Homo sapiens	104-113
16546682-3	2006	The present study reports a method to construct a chimera of phosphorodiamidate morpholino nucleobase oligomer (MORF) covalently conjugated to a peptide containing a cell membrane transduction Tat peptide and an N(2)S(2) chelator for technetium-99m ((99m)Tc) radiolabeling (N(2)S(2)-Tat-MORF).	Technetium-99	234-247	lysine acetyltransferase 6B	Homo sapiens	112-116
17409678-0	2007	On-site preparation of technetium-99m labeled human serum albumin for clinical application.	Technetium-99	23-36	albumin	Homo sapiens	52-65
17409678-1	2007	Technetium-99m labeled human serum albumin (Tc-99m HSA) is an important radiopharmaceutical for clinical applications, such as cardiac function tests or protein-losing gastroenteropathy assessment.	Technetium-99	0-13	albumin	Homo sapiens	29-42
17892130-0	2007	[Technetium-99m labeled synaptotagmin I C2A detection of paclitaxel-induced apoptosis in non-small cell lung cancer].	Technetium-99	1-14	synaptotagmin I	Mus musculus	24-39
17111160-5	2007	Expression of caveolin-1 at the protein level in renal tissue and urine was demonstrated in patients with technetium 99 m labeled diethylene triamine pentaacetate ((99)Tc DTPA) renal scan 28.8+/-2% and increased tubular interstitial fibrosis in seven patients at the time of obstruction release.	Technetium-99	106-119	caveolin 1	Homo sapiens	14-24
17257073-1	2006	UNLABELLED: In addition to tumor size, it has been suggested that P-glycoprotein (P-gp) expression and/or oxyphilic cell content in parathyroid adenomas has an important influence on the results of technetium 99m methoxyisobutylisonitrile (Tc-99m MIBI) parathyroid imaging.	Technetium-99	198-211	ATP binding cassette subfamily B member 1	Homo sapiens	66-80
17257073-1	2006	UNLABELLED: In addition to tumor size, it has been suggested that P-glycoprotein (P-gp) expression and/or oxyphilic cell content in parathyroid adenomas has an important influence on the results of technetium 99m methoxyisobutylisonitrile (Tc-99m MIBI) parathyroid imaging.	Technetium-99	198-211	ATP binding cassette subfamily B member 1	Homo sapiens	82-86
16546682-3	2006	The present study reports a method to construct a chimera of phosphorodiamidate morpholino nucleobase oligomer (MORF) covalently conjugated to a peptide containing a cell membrane transduction Tat peptide and an N(2)S(2) chelator for technetium-99m ((99m)Tc) radiolabeling (N(2)S(2)-Tat-MORF).	Technetium-99	234-247	tyrosine aminotransferase	Homo sapiens	193-196
15081753-0	2004	Accumulation of technetium-99 in the Irish Sea?	Technetium-99	16-29	S13 erythroblastosis (avian) oncogene homolog	Homo sapiens	43-46
16617402-2	2006	The findings in this case were compared with the intravenously injected methylene disphosphonate technetium-99m ((99m)Tc-MDP) scintigraphic findings and could be interpreted as the result of (99m)Tc-pertechenate through blood communication from the right to the left knee.	Technetium-99	97-110	dipeptidase 1	Homo sapiens	121-124
17406220-3	2006	Here we describe the most used method for labeling annexin V, a protein with a high affinity for apoptotic cells in vitro, with technetium-99m (99mTc) as a radionuclide imaging agent that can localize and non-invasively quantify apoptosis in vivo when coupled with single-photon emission tomography.	Technetium-99	128-141	annexin A5	Homo sapiens	51-60
16097634-4	2005	Anti-IL-6-receptor antibodies were conjugated with a bifunctional chelating agent, hydrazinonicotinamide (HYNIC), and radiolabeled with technetium-99m (99mTc) using the ligand exchange reaction of 99mTc-tricine complex.	Technetium-99	136-149	interleukin 6	Homo sapiens	5-9
14676140-4	2003	Animals were injected with human recombinant annexin V labeled with technetium-99m before imaging.	Technetium-99	68-81	annexin A5	Homo sapiens	45-54
15068617-0	2004	In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging.	Technetium-99	56-69	cholecystokinin B receptor	Mus musculus	101-115
14514974-1	2003	The purpose of this study was to predict chemotherapy response by technetium-99m methoxyisobutylisonitrile (Tc-99m MIBI) lung single-photon-emission computed tomography (SPECT) and compare P-glycoprotein (Pgp) expression in patients with untreated small cell lung cancer (SCLC).	Technetium-99	66-79	ATP binding cassette subfamily B member 1	Homo sapiens	205-208
14521888-1	2003	AIM: The aim of this study was to evaluate the effectiveness of technetium-99m tetrofosmin (Tc-99m TF) single photon emission computed tomography (SPECT) of the neck and chest to detect metastatic lesions in papillary thyroid carcinoma (PTC) after near total thyroidectomy and radioiodine (I-131) treatment in patients who present with elevated serum human thyroglobulin (hTg) levels but negative I-131 whole body scan (WBS).	Technetium-99	64-77	thyroglobulin	Homo sapiens	357-370
12960470-3	2003	A boost in the research in this direction has been provided by noninvasive means of detection of apoptosis, such as that achieved by technetium-99m labeled Annexin-A5 scintigraphy.	Technetium-99	133-146	annexin A5	Homo sapiens	156-166
12657370-7	2003	Technetium-99m (99mTc)-radiolabeling of the annexin V and superparamagnetic iron oxide (SPIO) labeling of the C2 domain of synaptotagmin I allow good in vivo apoptosis detection by gamma camera imaging and MRI, respectively.	Technetium-99	0-13	annexin A5	Homo sapiens	44-53
12915065-0	2003	Sea-to-land transfer of technetium-99 through the use of contaminated seaweed as an agricultural soil conditioner.	Technetium-99	24-37	S13 erythroblastosis (avian) oncogene homolog	Homo sapiens	0-3
12438528-5	2002	In this study, we show that the CRH-receptor antagonist Antalarmin blocks stress-induced 99Tc extravasation, whereas site-specific injection of CRH in the paraventricular nucleus (PVN) of the hypothalamus mimics acute stress.	Technetium-99	89-93	corticotropin releasing hormone	Rattus norvegicus	32-35